Země: Nový Zéland
Jazyk: angličtina
Zdroj: Medsafe (Medicines Safety Authority)
Aripiprazole 15mg
CARSL Consulting
Aripiprazole 15 mg
15 mg
Tablet
Active: Aripiprazole 15mg Excipient: Hyprolose Lactose monohydrate Magnesium stearate Maize starch Microcrystalline cellulose
Prescription
Ind-Swift Laboratories Limited
Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy. Aripiprazole monotherapy is indicated for acute and maintenance treatment of manic and mixed episodes with Bipolar I Disorder with or without psychotic features. Aripiprazole is indicated as an adjunctive therapy to either lithium or valporate for the acute treatment of manic and mixed episodes associated with Bipolar I Disorder with or without psychotic features.
Package - Contents - Shelf Life: Blister pack, Al/Al - 30 tablets - 36 months from date of manufacture stored at or below 30°C
2013-05-10